Publication
Understanding hydrogen in the EU
Green Hydrogen has been a central pillar of the EU’s energy and climate neutrality strategy since the adoption of the EU Hydrogen Strategy in 2020.
Canada | Publication | April 20, 2020 – 5 PM ET
Around the globe, pharmaceutical and medical device companies are helping in the fight of the COVID-19 pandemic. Many of these companies may have patents pertaining to technology that could be used for the benefit of the broader public during this time of crisis, such as patents on ventilators, diagnostic tests, pharmaceuticals or personal protective equipment. Governments around the globe have mechanisms in place that can mandate the use of patented inventions during a national emergency.
The reference guide provides a high-level overview of the governmental authorization provisions in Canada, the United States, France, Germany, the Netherlands, the United Kingdom, Hong Kong, China, Singapore and Australia.
Publication
Green Hydrogen has been a central pillar of the EU’s energy and climate neutrality strategy since the adoption of the EU Hydrogen Strategy in 2020.
Publication
Taking your company public is an important milestone, and whilst the landscape for IPOs is complex and dynamic, choosing the right path is essential.
Publication
On 10 July 2025, the UK government published its Review of Electricity Market Arrangements (REMA) Summer Update, which sets out the long-awaited outcome of the REMA programme and next steps towards a decarbonised, affordable, secure and efficient electricity market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025